252 related articles for article (PubMed ID: 28914645)
21. Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
Purow B
Curr Pharm Biotechnol; 2009 Feb; 10(2):154-60. PubMed ID: 19199947
[TBL] [Abstract][Full Text] [Related]
22. Notch regulation of tumor angiogenesis.
Bridges E; Oon CE; Harris A
Future Oncol; 2011 Apr; 7(4):569-88. PubMed ID: 21463145
[TBL] [Abstract][Full Text] [Related]
23. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
24. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.
Sparaneo A; Fabrizio FP; Muscarella LA
Oxid Med Cell Longev; 2016; 2016():7316492. PubMed ID: 27847554
[TBL] [Abstract][Full Text] [Related]
25. Notch inhibition as a promising new approach to cancer therapy.
Purow B
Adv Exp Med Biol; 2012; 727():305-19. PubMed ID: 22399357
[TBL] [Abstract][Full Text] [Related]
26. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
27. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
Weiss GJ
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
[No Abstract] [Full Text] [Related]
28. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Cao Y; Yu L; Dai G; Zhang S; Zhang Z; Gao T; Guo W
Eur J Pharmacol; 2017 Jan; 794():77-84. PubMed ID: 27845066
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
[TBL] [Abstract][Full Text] [Related]
30. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
31. Targeting Notch as a Therapeutic Approach for Human Malignancies.
Platonova N; Lesma E; Basile A; Bignotto M; Garavelli S; Palano MT; Moschini A; Neri A; Colombo M; Chiaramonte R
Curr Pharm Des; 2017; 23(1):108-134. PubMed ID: 27719637
[TBL] [Abstract][Full Text] [Related]
32. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
33. The Notch pathway in colorectal cancer.
Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
[TBL] [Abstract][Full Text] [Related]
34. Recent development of targeted approaches for the treatment of breast cancer.
Maruthanila VL; Elancheran R; Kunnumakkara AB; Kabilan S; Kotoky J
Breast Cancer; 2017 Mar; 24(2):191-219. PubMed ID: 27796923
[TBL] [Abstract][Full Text] [Related]
35. Notch signaling in development and cancer.
Bolós V; Grego-Bessa J; de la Pompa JL
Endocr Rev; 2007 May; 28(3):339-63. PubMed ID: 17409286
[TBL] [Abstract][Full Text] [Related]
36. [The Notch signaling system and oncogenesis].
Aleĭnik AN; Kondakova IV
Vopr Onkol; 2012; 58(5):593-7. PubMed ID: 23600274
[TBL] [Abstract][Full Text] [Related]
37. Notch-out for breast cancer therapies.
Lamy M; Ferreira A; Dias JS; Braga S; Silva G; Barbas A
N Biotechnol; 2017 Oct; 39(Pt B):215-221. PubMed ID: 28842360
[TBL] [Abstract][Full Text] [Related]
38. Indolocarbazole alkaloid Loonamycin A inhibits triple-negative breast cancer cell stemness and Notch signalling.
Xue W; Li W; Yu Y; Zhang B; Wang Y; Zhou L; Chen Z; Wang L; Ge H; Xu Q; Shen Y
J Pharm Pharmacol; 2023 Apr; 75(4):523-532. PubMed ID: 36861187
[TBL] [Abstract][Full Text] [Related]
39. Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer.
Dong Y; Li A; Wang J; Weber JD; Michel LS
Cancer Res; 2010 Jul; 70(13):5465-74. PubMed ID: 20570903
[TBL] [Abstract][Full Text] [Related]
40. Notch signaling and breast cancer.
Reedijk M
Adv Exp Med Biol; 2012; 727():241-57. PubMed ID: 22399352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
